Literature DB >> 21725363

Functional differences among BRCA1 missense mutations in the control of centrosome duplication.

Z Kais1, N Chiba, C Ishioka, J D Parvin.   

Abstract

We analyzed the effects of 14 different missense mutations in the RING domain of BRCA1 on the function of the protein in the control of centrosome number in tissue culture cells. Whereas 2 of the 14 BRCA1 variant proteins were neutral in the centrosome duplication assay, missense mutations of zinc-coordinating residues (C24R, C27A, C39Y, H41F, C44F and C47G) and mutations encoding BRCA1 variants M18T and I42V resulted in BRCA1 proteins that caused centrosome amplification. BRCA1 variant proteins I21V, I31M, L52F and D67Y had an intermediate effect on centrosome duplication. In addition, one of the variants, L52F, caused a peculiar phenotype with amplified centrosomes but the centrioles remained paired. By comparison, other BRCA1 variants that caused centrosome amplification had clustering of supernumerary centrosomes with unpaired centrioles. This surprising phenotype suggests that the BRCA1 protein regulates two functions in the control of centrosome duplication: regulation of centrosome number and regulation of centriole pairing. The L52F is unusual as it is defective in only one of these processes. This study analyzes the function of BRCA1 missense mutations in the control of centrosome duplication, a critical step in the maintenance of genetic stability of mammary epithelial cells, and indicates a new function of BRCA1 in the control of centriole pairing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725363      PMCID: PMC4222025          DOI: 10.1038/onc.2011.271

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  GFP-centrin as a marker for centriole dynamics in the human breast cancer cell line MCF-7.

Authors:  A B D'Assoro; F Stivala; S Barrett; G Ferrigno; J L Salisbury
Journal:  Ital J Anat Embryol       Date:  2001

Review 2.  Centrosome aberrations: cause or consequence of cancer progression?

Authors:  Erich A Nigg
Journal:  Nat Rev Cancer       Date:  2002-11       Impact factor: 60.716

3.  CBP/p300 interact with and function as transcriptional coactivators of BRCA1.

Authors:  G M Pao; R Janknecht; H Ruffner; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

4.  Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.

Authors:  Peter S Brzovic; Jennifer R Keeffe; Hiroyuki Nishikawa; Keiko Miyamoto; David Fox; Mamoru Fukuda; Tomohiko Ohta; Rachel Klevit
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

5.  The BRCA1 and BARD1 association with the RNA polymerase II holoenzyme.

Authors:  Natsuko Chiba; Jeffrey D Parvin
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

6.  BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.

Authors:  Lea M Starita; Yuka Machida; Satish Sankaran; Joshua E Elias; Karen Griffin; Brian P Schlegel; Steven P Gygi; Jeffrey D Parvin
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 7.  The good, the bad and the ugly: the practical consequences of centrosome amplification.

Authors:  Greenfield Sluder; Joshua J Nordberg
Journal:  Curr Opin Cell Biol       Date:  2004-02       Impact factor: 8.382

8.  Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity.

Authors:  H Ruffner; C A Joazeiro; D Hemmati; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

9.  The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript.

Authors:  A Vega; B Campos; B Bressac-De-Paillerets; P M Bond; N Janin; F S Douglas; M Domènech; M Baena; C Pericay; C Alonso; A Carracedo; M Baiget; O Diez
Journal:  Hum Mutat       Date:  2001-06       Impact factor: 4.878

10.  Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.

Authors:  Derek J R Ransburgh; Natsuko Chiba; Chikashi Ishioka; Amanda Ewart Toland; Jeffrey D Parvin
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

View more
  22 in total

1.  NUSAP1 influences the DNA damage response by controlling BRCA1 protein levels.

Authors:  Shweta Kotian; Tapahsama Banerjee; Ainsley Lockhart; Kun Huang; Umit V Catalyurek; Jeffrey D Parvin
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742

Review 2.  BRCA1 gene: function and deficiency.

Authors:  Miho Takaoka; Yoshio Miki
Journal:  Int J Clin Oncol       Date:  2017-09-07       Impact factor: 3.402

3.  Predicting pathogenicity of missense variants with weakly supervised regression.

Authors:  Yue Cao; Yuanfei Sun; Mostafa Karimi; Haoran Chen; Oluwaseyi Moronfoye; Yang Shen
Journal:  Hum Mutat       Date:  2019-08-07       Impact factor: 4.878

4.  Analysis of BRCA1 variants in double-strand break repair by homologous recombination and single-strand annealing.

Authors:  William I Towler; Jie Zhang; Derek J R Ransburgh; Amanda E Toland; Chikashi Ishioka; Natsuko Chiba; Jeffrey D Parvin
Journal:  Hum Mutat       Date:  2012-12-12       Impact factor: 4.878

Review 5.  A guide for functional analysis of BRCA1 variants of uncertain significance.

Authors:  Gaël A Millot; Marcelo A Carvalho; Sandrine M Caputo; Maaike P G Vreeswijk; Melissa A Brown; Michelle Webb; Etienne Rouleau; Susan L Neuhausen; Thomas v O Hansen; Alvaro Galli; Rita D Brandão; Marinus J Blok; Aneliya Velkova; Fergus J Couch; Alvaro N A Monteiro
Journal:  Hum Mutat       Date:  2012-07-16       Impact factor: 4.878

6.  The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays.

Authors:  Aleksandra I Adamovich; Mariame Diabate; Tapahsama Banerjee; Gregory Nagy; Nahum Smith; Kathryn Duncan; Erika Mendoza Mendoza; Gisselle Prida; Michael A Freitas; Lea M Starita; Jeffrey D Parvin
Journal:  Am J Hum Genet       Date:  2022-02-22       Impact factor: 11.043

7.  BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.

Authors:  Jianqiu Zou; Deli Zhang; Guang Qin; Xiangming Chen; Hongmin Wang; Dong Zhang
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  In-Silico Analyses of Nonsynonymous Variants in the BRCA1 Gene.

Authors:  Sidra Arshad; Irfan Ishaque; Sidra Mumtaz; Muhammad Usman Rashid; Naila Malkani
Journal:  Biochem Genet       Date:  2021-05-04       Impact factor: 1.890

9.  BRCA1 Circos: a visualisation resource for functional analysis of missense variants.

Authors:  Ankita Jhuraney; Aneliya Velkova; Randall C Johnson; Bailey Kessing; Renato S Carvalho; Phillip Whiley; Amanda B Spurdle; Maaike P G Vreeswijk; Sandrine M Caputo; Gael A Millot; Ana Vega; Nicolas Coquelle; Alvaro Galli; Diana Eccles; Marinus J Blok; Tuya Pal; Rob B van der Luijt; Marta Santamariña Pena; Susan L Neuhausen; Talia Donenberg; Eva Machackova; Simon Thomas; Maxime Vallée; Fergus J Couch; Sean V Tavtigian; J N Mark Glover; Marcelo A Carvalho; Lawrence C Brody; Shyam K Sharan; Alvaro N Monteiro
Journal:  J Med Genet       Date:  2015-02-02       Impact factor: 6.318

10.  Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes.

Authors:  Rory L Cochran; Justin Cidado; Minsoo Kim; Daniel J Zabransky; Sarah Croessmann; David Chu; Hong Yuen Wong; Julia A Beaver; Karen Cravero; Bracha Erlanger; Heather Parsons; Christopher M Heaphy; Alan K Meeker; Josh Lauring; Ben Ho Park
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.